MaxCyte, Inc. (MXCT) vs Neuronetics, Inc. (STIM)
- MaxCyte, Inc. MXCT 1.30 0.00%
- Neuronetics, Inc. STIM 1.89 −3.08%
MaxCyte, Inc. and Neuronetics, Inc. are both Medical Devices companies. Neuronetics, Inc. is the larger, with a market value of $148.6M against $134.2M — 1.1× the size. Neuronetics, Inc. grew revenue faster over the last twelve months: 39.6% against −13.2%. Neuronetics, Inc. has the higher net margin (−19.6% vs −114.8%) and the higher return on invested capital (−24.6% vs −49.2%). Across the 18 metrics below, Neuronetics, Inc. leads on 12 and MaxCyte, Inc. on 6.
Valuation
Profitability
| Metric | MXCT | STIM | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 49.12% | 56.01% |
| Operating margin | (134.59%) | (14.74%) | (15.03%) |
| Net margin | (114.77%) | (19.62%) | (20.40%) |
| Free cash flow margin | (76.14%) | (7.24%) | (7.24%) |
| Return on equity | (20.39%) | (114.52%) | (15.32%) |
| Return on assets | (17.62%) | (22.87%) | (19.72%) |
| Return on invested capital | (49.23%) | (24.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack